In agreement with our results, MEK1 inhibitor has been shown to reverse PD‐associated phenotypes induced by pathological LRRK2 alleles in cultured human iPS derived neurons (Reinhardt et al., 2013). This evidence concerns the gene LRRK2 and Parkinson disease.